Figures computed from official regulatory filings — .
Analysttarget 12.29 USD (+21%) · consensus 4.57/5 · 6 buy · 1 hold · 0 sell
Ownershipinsiders 3.05% · institutions 60.12% · short 4.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for XERIS PHARMACEUTICALS INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
20 buys21 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| JOHNSON KENNETH ERLAND | Other | n/a (No price was disclosed in the filing) | SEC | ||
| Shannon John Patrick Jrtrack record |
| OtherD (derivative) |
| n/a (No price was disclosed in the filing) |
| SEC |
| PRESTRELSKI STEVEN | Other | n/a (No price was disclosed in the filing) | SEC |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Schmid John P.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PERSKY MARLA | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PRESTRELSKI STEVEN | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PRESTRELSKI STEVEN | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HALKUFF DAWN | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| JOHNSON KENNETH ERLAND | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PRESTRELSKI STEVEN | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PERSKY MARLA | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PERSKY MARLA | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Edick Paul Rtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Edick Paul Rtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Schmid John P.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| JOHNSON KENNETH ERLAND | Other | n/a (No price was disclosed in the filing) | SEC |
| Schmid John P.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PRESTRELSKI STEVEN | Other | n/a (No price was disclosed in the filing) | SEC |
| Schmid John P.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Pieper Steven | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HALKUFF DAWN | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SHERMAN JEFFREY W | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shannon John Patrick Jrtrack record | Other | n/a (No price was disclosed in the filing) | SEC |
| JOHNSON KENNETH ERLAND | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |